Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Safety: early-phase trial registry
3 of 11 indexed Safety trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 3 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Safety: 11 US clinical trials tracked, 3 recruiting.
Safety is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Altasciences Company, running 1 of these trials.
Enrollment posture brief
Registry condition safety
OPEN 3 | RECR 27% | LATE 2 | EARLY 6 | RANK #1577 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Atherosclerotic Cardiovascular Disease (27% recruiting · 22 trials)
Safety lists 3 open slots (27% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Safety on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Safety is recruiting below its size-band peers.
3 of 11 indexed trials (27.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Safety trials is spread across many organizations.
Altasciences Company accounts for 1 of 11 trials (9.1%). 11 distinct sponsors appear on at least one study for this condition label.
-
Most Safety trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 11 trials that report a genuine target (sentinel values excluded). 7 of those (63.6%) plan for fewer than 100 participants.
-
Safety research is mostly interventional.
10 interventional and 1 observational studies make up this index (90.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Curcumin and Retinal Study
Texas Tech University Health Sciences Center
NCT05774704
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Basilea Pharmaceutica
NCT06733675
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
ARJ Medical
NCT05276557
Prospective G7 Dual Mobility Total Hip PMCF
Zimmer Biomet
NCT03308929
Developing a Dyadic Shared Decision Making Tool About Firearm Storage
Seattle Children's Hospital
NCT05451355
Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects
Actelion
NCT02206204
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
Novartis Pharmaceuticals
NCT01576666
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
Duke University
NCT06503900
Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience
Altasciences Company
NCT06072170
Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers
University of Memphis
NCT05592951
Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb
Spectrum Pharmaceuticals
NCT01560884
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Safety records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Safety trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Safety page
11 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Safety trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Altasciences Company sponsors the most Safety trials on record, review their full trial history before evaluating a specific study. See Altasciences Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Safety condition card totals 11 registered trials; most-linked intervention moxifloxacin-matching placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.